Sort   by:  
 Page size 
UnknownCCAAT/enhancer binding protein β directly regulates the expression of the complement component 3 gene in neural cells: implications for the pro-inflammatory effects of this transcription factor.
Not available
S-EPMC4348118 | biostudies-literature
UnknownCCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4.
Not available
S-EPMC4414196 | biostudies-literature
UnknownCCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease.
Not available
S-EPMC5648790 | biostudies-literature
UnknownGlycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.
Not available
S-EPMC3503340 | biostudies-literature
UnknownGlycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease.
Not available
S-EPMC3582296 | biostudies-literature
UnknownPGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes.
Not available
S-EPMC4973357 | biostudies-literature
UnknownInternational Impact of COVID-19 on the Diagnosis of Heart Disease.
Not available
S-EPMC7836433 | biostudies-literature
UnknownImpact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World.
Not available
S-EPMC8374310 | biostudies-literature
UnknownWorldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19.
Not available
S-EPMC9109706 | biostudies-literature
UnknownImpact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study.
Not available
S-EPMC9627847 | biostudies-literature
Sort   by:  
 Page size